Nitrocefin for β-Lactamase Assay Workflows

2026-09-28

Use Nitrocefin’s yellow-to-red response to screen β-lactamase activity, compare enzyme preparations, and prioritize follow-up experiments. The workflow also explains why a positive signal is a useful starting point—not a substitute for measuring hydrolysis of clinically relevant antibiotics or determining susceptibility.

Rotigotine Workflows for Parkinson’s Disease Research

2026-09-27

Rotigotine supports experiments that connect dopamine-receptor activation with motor and neuroprotective outcomes in Parkinson’s disease models. This guide translates its continuous-delivery rationale into practical cell and animal workflows, with dosing boundaries and troubleshooting considerations for reproducible studies.

Lisinopril Dihydrate: From ACE Biology to Models

2026-09-26

A translational guide to using Lisinopril dihydrate in cardiovascular and renal research. It connects ACE pathway modulation to experimental design, highlights what cell-surface peptidase selectivity studies do—and do not—establish, and outlines practical steps for stronger target-engagement and model interpretation.

Berberine hydrochloride in gut–bone research

2026-09-25

Translate emerging gut–bone axis findings into practical workflows for studying tuft cells, intestinal barrier function, immune balance, and bone resorption. Includes formulation guidance, assay controls, troubleshooting, and a clear distinction between published findings and proposed starting conditions.

Pentoxifylline Workflows for Inflammation and Psoriasis

2026-09-25

Use Pentoxifylline to probe cAMP-linked inflammatory signaling, then extend the workflow to topical co-delivery studies in psoriasis. A niosome optimization study offers practical formulation benchmarks while underscoring why skin retention, controls, and viability checks matter.

Cisapride (R 51619): From Ion Channels to iPSC Screens

2026-09-24

How Cisapride can help translational teams connect hERG channel inhibition, 5-HT4 receptor biology, and human iPSC-cardiomyocyte phenotyping—while keeping mechanistic interpretation and assay limitations in view.

(R)-MG132 as a Proteasome Negative Control

2026-09-24

Learn how to use (R)-MG132 (SKU C3348) as a stereoisomeric negative control when interpreting proteasome-dependent effects in cell-based assays. This practical guide covers control design, solution handling, data interpretation, and vendor-selection considerations without assuming that a negative control is biologically inert.

Hoechst 33342 for Hypoxia Crosstalk Assays

2026-09-23

Use Hoechst 33342 to turn changes in nuclear number and morphology into a practical readout in endothelial–smooth muscle cell hypoxia experiments. This workflow explains how to pair nuclear imaging with the SP1/ADAM10/DRP1 findings while avoiding the common mistake of treating a DNA stain as proof of apoptosis or pathway activation.

Proteomimetics Target the SARS-CoV-2 S-RBD/hACE2 Interface

2026-09-23

Sulfisomidine: Assay Workflows and Optimization

2026-09-22

Sulfisomidine supports two complementary research workflows: PABA-pathway inhibition in microbial models and mixed-type modulation of human serum paraoxonase 1. This practical guide covers solvent selection, concentration design, kinetic interpretation, historical evidence, and troubleshooting for reproducible in vitro studies.

Nitrocefin for β-Lactamase Assays

2026-09-22

Nitrocefin provides a rapid visual and spectrophotometric route to β-lactamase activity measurement in purified enzymes, lysates, and microbial resistance studies. This guide connects practical assay design with GOB-38 research, emphasizing substrate selection, inhibitor screening, controls, and troubleshooting.

Deracoxib–Doxorubicin in Canine Mammary Cells

2026-09-21

The 2017 reference study examined whether Deracoxib could protect cultured normal canine mammary epithelial cells from doxorubicin-associated injury. Its combination of MTT viability testing, flow-cytometric apoptosis analysis, and nitrite measurement links a selective COX-2 inhibitor with cytoprotection and nitric oxide modulation, while also defining important limits for translational interpretation.

Dabigatran etexilate Research Workflow Guide

2026-09-21

Dabigatran etexilate supports mechanistic thrombin assays, plasma clotting studies, and translational anticoagulant research with a distinct prodrug-conversion consideration. This guide connects solvent handling, assay selection, controls, and troubleshooting for atrial fibrillation and coagulation workflows.

Indole-3-pyruvic Acid: From Metabolite to Strategy

2026-09-20

Indole-3-pyruvic acid connects auxin biosynthesis, AhR-linked immune biology, and microbiome–cancer signaling. This translational guide examines its mechanisms, evidence, experimental use, and strategic value beyond a conventional product page.

Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor

2026-09-19

Z-LEHD-FMK helps researchers test whether mitochondria-driven caspase-9 signaling is required for apoptosis, rather than merely correlating cell death with a final endpoint. This practical guide connects inhibitor timing, caspase activity measurement, annexin-V imaging, cancer research, and neuroprotection in spinal cord injury models.